The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Molecular parameters impacting the success rate of a lung cancer PDX model.
 
Ziyi Li
No Relationships to Disclose
 
Shawna Marie Hubert
No Relationships to Disclose
 
Ran Zhang
No Relationships to Disclose
 
Xingzhi Song
No Relationships to Disclose
 
Tatiana Karpinets
No Relationships to Disclose
 
Annikka Weissferdt
No Relationships to Disclose
 
Latasha Little
No Relationships to Disclose
 
Mohammad Mohammad
Employment - NeoGenomics Laboratories (I)
Consulting or Advisory Role - Guidepoint Inc
 
Curtis Gumbs
Patents, Royalties, Other Intellectual Property - BRCA-2
 
Marcelo Vailati Negrao
Consulting or Advisory Role - Merck; Mirati Therapeutics
Research Funding - Alaunos Therapeutics; AstraZeneca; Checkmate Pharmaceuticals; Genentech; Mirati Therapeutics; Novartis; Pfizer; ZIOPHARM Oncology
Other Relationship - Apothecom; Ashfield Healthcare; ZIOPHARM Oncology
 
Jianhua Zhang
No Relationships to Disclose
 
Apar Pataer
No Relationships to Disclose
 
Stephen Swisher
Honoraria - Armada Health Care (I); Merck (I)
Research Funding - CairnSurgical (I); Lilly (I); Lumicell (I); OncoNano Inc (I)
Travel, Accommodations, Expenses - Peter MacCallum Cancer Center
 
Ara A. Vaporciyan
No Relationships to Disclose
 
Jack A. Roth
Stock and Other Ownership Interests - Genprex
Consulting or Advisory Role - Genprex
Research Funding - Genprex; Varian Medical Systems
Patents, Royalties, Other Intellectual Property - Patents licensed by Genprex
 
John Heymach
Stock and Other Ownership Interests - Bio-Tree; Cardinal Spine
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; BrightPath Biotheraputics; Bristol-Myers Squibb; Catalyst Biotech; EMD Serono; Foundation medicine; Genentech/Roche; GlaxoSmithKline; Guardant Health; Hengrui Pharmaceutical; Janssen; Kairos Ventures; Leads Biolabs; Lilly; Mirati Therapeutics; Nexus Health Systems; Novartis; Pneuma Respiratory; Roche; Sanofi/Aventis; Spectrum Pharmaceuticals; Takeda
Research Funding - AstraZeneca (Inst); GlaxoSmithKline; Spectrum Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Licensing agreement between Spectrum and MD Anderson (including myself) regarding intellectual property for treatment of EGFR and HER2 exon 20 mutations
 
Boris Sepesi
Consulting or Advisory Role - Bristol-Myers Squibb/Medarex
Speakers' Bureau - AstraZeneca
 
Don Lynn Gibbons
Stock and Other Ownership Interests - Exact Sciences; Nektar
Consulting or Advisory Role - GlaxoSmithKline; Janssen Research & Development; Lilly; Menarini; Mitobridge; Napa Therapeutics; Ribon Therapeutics; Sanofi
Research Funding - AstraZeneca; Boehringer Ingelheim (Inst); Janssen Research & Development; Mirati Therapeutics (Inst); Mitobridge; NGM Biopharmaceuticals; Ribon Therapeutics; Takeda
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; BerGenBio; Takeda
 
Bingliang Fang
No Relationships to Disclose
 
Jianjun Zhang
Honoraria - CancerNet; Geneplus; Geneplus; innovent biologics; Innovent Biologics; Innovent Biologics; Origimed; Roche; Sino-USA Biomedical Platform; Zhejiang Cancer Hospital; Zhejiang Cancer Hospital
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca; Capital Medical University; Geneplus; Johnson & Johnson/Janssen; Novartis
Research Funding - Merck; Novartis
Travel, Accommodations, Expenses - innovent biologics; Zhejiang Cancer Hospital